These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 8070005

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Systemic administration of alkylphosphocholines. Erucylphosphocholine and liposomal hexadecylphosphocholine.
    Kaufmann-Kolle P, Berger MR, Unger C, Eibl H.
    Adv Exp Med Biol; 1996; 416():165-8. PubMed ID: 9131143
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Evaluation of release and pharmacokinetics of hexadecylphosphocholine (miltefosine) in phosphatidyldiglycerol-based thermosensitive liposomes.
    Rysin A, Paal M, Lokerse WJM, Wedmann B, Hossann M, Vogeser M, Winter G, Lindner LH.
    Biochim Biophys Acta Biomembr; 2021 Nov 01; 1863(11):183698. PubMed ID: 34283999
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Therapeutic activity of ET-18-OCH3 and hexadecylphosphocholine against mammary tumors in BD-VI rats.
    Scherf HR, Schuler B, Berger MR, Schmähl D.
    Lipids; 1987 Nov 01; 22(11):927-9. PubMed ID: 3444387
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Alkylphosphocholines: influence of structural variation on biodistribution at antineoplastically active concentrations.
    Kötting J, Berger MR, Unger C, Eibl H.
    Cancer Chemother Pharmacol; 1992 Nov 01; 30(2):105-12. PubMed ID: 1600590
    [Abstract] [Full Text] [Related]

  • 11. Effect of miltefosine on transplanted methylnitrosourea-induced mammary carcinoma growing in Fischer 344 rats.
    Reinhardt M, Heyl P, Amelung F, Berger MR.
    Arzneimittelforschung; 1992 Oct 01; 42(10):1239-42. PubMed ID: 1282010
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Chemopreventive effects of the aromatase inhibitor vorozole (R 83842) in the methylnitrosourea-induced mammary cancer model.
    Lubet RA, Steele VE, DeCoster R, Bowden C, You M, Juliana MM, Eto I, Kelloff GJ, Grubbs CJ.
    Carcinogenesis; 1998 Aug 01; 19(8):1345-51. PubMed ID: 9744527
    [Abstract] [Full Text] [Related]

  • 15. Hexadecylphosphocholine differs from conventional cytostatic agents.
    Berger MR, Betsch B, Gebelein M, Amtmann E, Heyl P, Scherf HR.
    J Cancer Res Clin Oncol; 1993 Aug 01; 119(9):541-8. PubMed ID: 8392075
    [Abstract] [Full Text] [Related]

  • 16. Activity, pharmacokinetics and tissue distribution of TLC ELL-12 (liposomal antitumor ether lipid) in rats with transplantable, s.c. methylnitrosourea-induced tumors.
    Bhamra R, Bolcsak LE, Ahmad I, Schupsky J, Roberts P, Stevens R, Cavanaugh C, Swenson CE.
    Anticancer Drugs; 2003 Jul 01; 14(6):481-6. PubMed ID: 12853892
    [Abstract] [Full Text] [Related]

  • 17. A liposomal formulation of doxorubicin, composed of hexadecylphosphocholine (HePC): physicochemical characterization and cytotoxic activity against human cancer cell lines.
    Papagiannaros A, Hatziantoniou S, Dimas K, Papaioannou GT, Demetzos C.
    Biomed Pharmacother; 2006 Jan 01; 60(1):36-42. PubMed ID: 16271845
    [Abstract] [Full Text] [Related]

  • 18. Alkyl phosphocholines: toxicity and anticancer properties.
    Muschiol C, Berger MR, Schuler B, Scherf HR, Garzon FT, Zeller WJ, Unger C, Eibl HJ, Schmähl D.
    Lipids; 1987 Nov 01; 22(11):930-4. PubMed ID: 3444388
    [Abstract] [Full Text] [Related]

  • 19. Antitumor activity of alkylphosphocholines and analogues in methylnitrosourea-induced rat mammary carcinomas.
    Berger MR, Yanapirut P, Reinhardt M, Klenner T, Scherf HR, Schmeiser HH, Eibl H.
    Prog Exp Tumor Res; 1992 Nov 01; 34():98-115. PubMed ID: 1438807
    [No Abstract] [Full Text] [Related]

  • 20. Antileishmanial and trypanocidal activities of new miltefosine liposomal formulations.
    Papagiannaros A, Bories C, Demetzos C, Loiseau PM.
    Biomed Pharmacother; 2005 Dec 01; 59(10):545-50. PubMed ID: 16325367
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.